2026 ICD-10-CM Diagnosis Code E26.89Other hyperaldosteronism

ICD-10-CM Codes›E00–E89›E20-E35›E26

ICD-10-CM E26.89
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

E26.89 is a billable ICD-10-CM diagnosis code for other hyperaldosteronism. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 643 through 645. Coders also document this condition as acquired pseudoprimary hyperaldosteronism. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified endocrine disorders.

Code Identity

ICD-10-CM Code
E26.89
Billable Status
Yes — Valid for Submission
Code Describes
Other hyperaldosteronism
Short Description
Other hyperaldosteronism
Same as the full description in the CMS dataset.
Parent Code
E26.8
Other hyperaldosteronism

Code Classification

ChapterE00–E89Endocrine, nutritional and metabolic diseases
SectionE20-E35Disorders of other endocrine glands
CategoryE26Hyperaldosteronism
This CodeE26.89Other hyperaldosteronism

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Acquired pseudoprimary hyperaldosteronism
  • Pseudoprimary hyperaldosteronism

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Aldosteronism
      • specified NEC
    • Hyperaldosteronism
      • specified NEC

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR END015
Other specified and unspecified endocrine disorders
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Hyperaldosteronism

    a condition caused by the overproduction of aldosterone. it is characterized by sodium retention and potassium excretion with resultant hypertension and hypokalemia.

Patient EducationClinical

Adrenal Gland Disorders

Your adrenal glands are two small organs that sit on top of each kidney. The adrenal glands make different types of hormones you need to stay alive and healthy. Hormones are chemicals that travel in your bloodstream and control how different parts of your body work.

The full article covers:

  • What are adrenal glands?
  • What are adrenal gland disorders?
  • What causes adrenal gland disorders?
  • How are adrenal gland disorders diagnosed?
  • What are the treatments for adrenal gland disorders?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert E26.89 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
255.14 Secondry aldosternsm NEC
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About E26.89Overview

Is E26.89 (Other hyperaldosteronism) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report other hyperaldosteronism on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does E26.89 group to?

When other hyperaldosteronism is the principal diagnosis on an inpatient stay, it groups to MS-DRG 643, 644, 645, with relative weights from 0.7683 to 1.6461 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of E26.89?

Under the General Equivalence Mappings, other hyperaldosteronism converts to ICD-9-CM 255.14 (secondry aldosternsm NEC). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.